drugsScienceWhy Nevada's Execution Drug Cocktail Is So ControversialBy Robbie GonzalezScienceHow Israel's weed tech industry is taking on America's opioid crisisBy Sean WilliamsScienceThe FDA Approved its First Cannabis Drug. What Next?By Fred VogelsteinScienceThese Beating Mini-Hearts Could Save Big Bucks—And Maybe LivesBy Megan MolteniScienceA Microguide to Microdosing Psychedelic DrugsBy Blanca MyersScienceVirtual reality is helping chemists discover new life-enhancing drugsBy Phoebe BraithwaiteScienceThe most exciting thing about Canada legalising weed? DataBy Bryan BorzykowskiThe Big StoryThe struggle to turn psychedelics into life-changing treatmentsBy Nicola DavisonScienceThe Hairy Problem With Drug TestingBy Ellen AirhartThe Big StoryThe UK's radical club drug safety experiment is working – and now it's going high-techBy Anna Codrea-RadoSecurityInside the Sting That Hijacked a Dark Web Drug MarketBy Andy GreenbergScienceInside the Mind of the Countess of Psychedelic ScienceBy Matt SimonScienceThis Company Wants to Democratize Clinical Trials With AIBy Megan MolteniScienceThe Second Coming of UltrasoundBy Megan MolteniScienceSalvia Leads Chemists on an Existential JourneyBy Matt SimonScienceThe Future of Weed Science Is a Van in ColoradoBy Robbie GonzalezScienceDrug safety YouTubers face a quiet crisis at the mercy of algorithmsBy Anna Codrea-RadoScienceWill Russia's Olympic Ban Shred the Culture of Doping?By Eric NiilerScienceNew Cancer Treatments Have Arrived—But Not for EveryoneBy Megan MolteniScienceRepurposing drugs could be key to fighting antibiotic resistanceBy Sian BradleyScienceExpensive drugs can trick you into experiencing worse side effectsBy Matt ReynoldsBusinessIndiana, Reeling from Opioid Crisis, Arms Officials with DataBy Issie LapowskyScienceThis AI unicorn is disrupting the pharma industry in a big wayBy João MedeirosScienceIn the future, there will be a pill for falling in loveBy Rich WordsworthMore Stories
